Discontinuation report AURO-ATOMOXETINE
Report ID | 210755 |
Drug Identification Number | 02471515 |
Brand name | AURO-ATOMOXETINE |
Common or Proper name | AURO-ATOMOXETINE |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | ATOMOXETINE |
Strength(s) | 40MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100's ans 30's |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2023-11-17 |
Remaining supply date | |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2023-11-18 | English | Compare |
v2 | 2023-11-17 | French | Compare |
v1 | 2023-11-17 | English | Compare |
Showing 1 to 3 of 3